Pinned Tweet
Wrapped the final investigator meeting for the ADOPT trial in Singapore! 🚀Grateful to our investigators, leads, coordinators & partners—what a 5-year journey of grit, growth & global teamwork. 18 months to go till home-run! Let’s finish strong! 📷 #ADOPTtrial
5
80
Chanchal Chandramouli retweeted
‼️ The most anticipated trial of the year
#ZEUS IL-6 inhibitor ziltivekimab does not reduce MACE in >6,300 people with ASCVD, CKD, and inflammation
hazard ratio 0.99; 95% confidence interval 0.88 to 1.11
uk.finance.yahoo.com/news/no…
📺 Catch my husband on Mediacorp’s Pesuvom this Tue, 18 Nov at 9.30pm on Vasantham as he breaks down prostate cancer with clarity, compassion, and the calm of someone who answers 200 patient questions before lunch.
👨⚕️✨ #ProstateCancer #MensHealth
2
60
🎥 Honored to join the APSC Webinar panel alongside inspiring colleagues discussing cardio-kidney-metabolic care in Asia 📷Such vibrant community driving cardiovascular science forward📷 Watch the full session: youtu.be/j-OXnHWzKQI?t=4720 #APSC #CardioRenalMetabolic #HeartFailure
Congratulations @lamcardio on the NMEA Clinician Scientist Award. Super proud to have been on the journey with you, in a small way. Thanks @SingHealthSG for the opportunity for us to conduct trials worldwide in an impactful way 🙏
2
42
Chanchal Chandramouli retweeted
ALCHEMIST & ACHIEVE in @TheLancet this week
Spironolactone does not reduce cardiovascular morbidity / mortality in hemodialysis patients
Huge congrats to Mike Walsh, Patrick Rossignol & all involved
thelancet.com/journals/lance…
thelancet.com/journals/lance…
Chanchal Chandramouli retweeted
📢 New Research from @CKMResearch @KPDOR @ankeetbhatt
"Cardiovascular-Kidney-Metabolic Syndrome: A Paradigm for Value-Based Care" proposes an integrated model to tackle urgent & costly health crisis in the U.S.
🔗 Read: onlinejcfi.org/article/S3050…
#ValueBasedCare #CKM #HealthEquity
Chanchal Chandramouli retweeted
Midway through an amazing robotic fellowship at the @enherts Lister hospital with @nikhilvasdevuro @MrTimLane @jimadshead Mr Ben Pullar and Mr Andy Brodie.
Is has been an immense 7 months so far with my co-fellow and obligate friends for life @MrRossWarner
Honoured to be joining this stellar line up of Lancet Commissioners for the next two years under the leadership of @lamcardio and @ProfSNicholls 🫀🫶🏼
Many voices, singular message - To reduce CVD burden in Asia-Pacific 🚀
#ESCcongress2024 #Lancet
Chanchal Chandramouli retweeted
Women on editorial boards: where are they?
📍26 EIC from 49 journals
📍20% women EIC 2023 🆚 5% 2013
📍 ⤴️26% women on editorial boards in 2023 (19% in 2013)
📍more women if EIC woman
📍why so few 💃🏻? Less WIC but also they state 💃🏻 “under qualified”
📎 rb.gy/2iytjy
Asymptomatic patients with type 2 diabetes and no heart failure:
🍿44% with cardiac abnormalities with NO elevation in NT-proBNP levels
🍿5% with elevated NT-proBNP and no cardiac abnormalities
🍿15% with BOTH elevated NT-proBNP AND cardiac abnormalities.
#ESCCongress2024
2
97
Chanchal Chandramouli retweeted
#ESCCongressVisuals for Hotline 7:
FINEARTS-HF - #Finerenone in #HeartFailure with mildly reduced and preserved ejection fraction
MRAs in #HF - An individual patient data meta-analysis of randomised trials
FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials
#ESCCongress
Chanchal Chandramouli retweeted
Implementing Medical Therapy During Worsening #HeartFailure released at #ESCCongress and just published in #EHJ👉 bit.ly/4cMFoUg
@ehj_ed @ankeetbhatt
A mini ADOPT reunion at @escardio #ESCCongress2024 who else is here? Come say hello!
1
7
142
Chanchal Chandramouli retweeted
Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) nej.md/3MeRHOi
Editorial: Routine Beta-Blockers in Secondary Prevention — Approaching Retirement? nej.md/3Me7EnW
#ESCardio | @escardio

ALT Kaplan–Meier estimates of the cumulative incidence of the primary cardiovascular composite end point (Panel A); the composite end point of death, nonfatal myocardial infarction, or nonfatal stroke (Panel B); the composite end point of death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure (Panel C); and death from any cause (Panel D).
Chanchal Chandramouli retweeted
📝New #OriginalResearch published in #CircOutcomes from @lamcardio et al:
Discordance between #KCCQ score and #NYHA class was common in HF and related to outcomes in #HFrEF and #HFpEF.
Read more: ahajournals.org/doi/abs/10.1… #AHAJournals @chanchal5688 @Claire_A_Lawson
What do you think is the most important factor in ensuring patients' positive attitude towards AI technology?
Performance? Ease of use? Social influence? Resources to support? Or the sheer fun of it?
💡We think it is ALL of the above!
Hot off the press: bmchealthservres.biomedcentr…








































